CCM
NVCR icon

Courage Capital Management’s NovoCure NVCR Stock Holding History

Courage Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-120,000
Closed -$6.29M – 22
2018
Q3 		$6.29M Buy
+120,000
New +$4.78M 3.41% 7

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Courage Capital Management's NVCR Position: Q2 2022 in Review

Courage Capital Management sold out of NovoCure (NVCR) in Q2 2022, closing a stake of 10,000 shares — an estimated $829K sold.

Courage Capital Management first reported a position in NVCR in Q3 2016 and held it in 23 quarters. The position peaked at $8.61M in Q2 2018. 316 funds tracked by Wall St. Rank hold NVCR as of Q2 2022.

  • Courage Capital Management reported no remaining NovoCure position as of Q2 2022 after selling out during the quarter.
  • Courage Capital Management sold 10,000 NovoCure shares in Q2 2022, an estimated $829K.
  • Courage Capital Management first reported a position in NovoCure in Q3 2016 and held it in 23 quarters.
  • Courage Capital Management's NovoCure position peaked at $8.61M in Q2 2018.
  • 316 funds tracked by Wall St. Rank held NovoCure as of Q2 2022.

Based on Courage Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.